Our top pick for
Cryoport, Inc is an integrated freight & logistics business based in the US. Cryoport shares (CYRX) are listed on the NASDAQ and all prices are listed in US Dollars. Cryoport employs 105 staff and has a trailing 12-month revenue of around USD$39.6 million.
|Latest market close||USD$47.18|
|52-week range||USD$13.01 - USD$63.36|
|50-day moving average||USD$49.5424|
|200-day moving average||USD$42.2999|
|Wall St. target price||USD$53.86|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.311|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-08)||-16.64%|
|1 month (2020-12-16)||-4.28%|
|3 months (2020-10-15)||-1.63%|
|6 months (2020-07-15)||44.99%|
|1 year (2020-01-15)||149.50%|
|2 years (2019-01-15)||439.20%|
|3 years (2018-01-12)||441.06%|
|5 years (2016-01-15)||2,190.29%|
|Revenue TTM||USD$39.6 million|
|Gross profit TTM||USD$17.4 million|
|Return on assets TTM||-4.32%|
|Return on equity TTM||-19.2%|
|Market capitalisation||USD$1.8 billion|
TTM: trailing 12 months
There are currently 7.4 million Cryoport shares held short by investors – that's known as Cryoport's "short interest". This figure is 1% down from 7.5 million last month.
There are a few different ways that this level of interest in shorting Cryoport shares can be evaluated.
Cryoport's "short interest ratio" (SIR) is the quantity of Cryoport shares currently shorted divided by the average quantity of Cryoport shares traded daily (recently around 730500.88495575). Cryoport's SIR currently stands at 10.17. In other words for every 100,000 Cryoport shares traded daily on the market, roughly 10170 shares are currently held short.
However Cryoport's short interest can also be evaluated against the total number of Cryoport shares, or, against the total number of tradable Cryoport shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cryoport's short interest could be expressed as 0.19% of the outstanding shares (for every 100,000 Cryoport shares in existence, roughly 190 shares are currently held short) or 0.2153% of the tradable shares (for every 100,000 tradable Cryoport shares, roughly 215 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Cryoport.
Find out more about how you can short Cryoport stock.
We're not expecting Cryoport to pay a dividend over the next 12 months.
Cryoport's shares were split on a 1:12 basis on 19 May 2015. So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cryoport shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Cryoport shares which in turn could have impacted Cryoport's share price.
Over the last 12 months, Cryoport's shares have ranged in value from as little as $13.01 up to $63.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cryoport's is 1.3328. This would suggest that Cryoport's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cryoport, Inc. provides temperature-controlled logistics and biostorage services to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Global Logistics Solutions and Global Bioservices. The Global Logistics Solutions segment offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures. This segment also provides Cryoport Express Advanced Therapy Shippers, which offer verification information and supply chain support for biopharma companies; and Cryoport Express C3 Shippers, a non-cryogenic temperature-controlled shipper designed to maintain a controlled temperature. In addition, it offers Cryoport Express SmartPak II Condition Monitoring System to track the key aspects and condition of each shipment; and Cryoport Express Analytics to track the time-based metrics for order processing time and on-time deliveries, as well as profiling shipping lanes to determine average transit times and predicting shipping exceptions based on historical metric. The Global Bioservices segment provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens. The company also offers logistics support and management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
Everything we know about the Gold Royalty Corp IPO, plus information on how to buy in.
Everything we know about the Bustle Digital Group IPO, plus information on how to buy in.
Everything we know about the Lucid Motors IPO, plus information on how to buy in.
Steps to owning and managing HFFG, with 24-hour and historical pricing before you buy.
Steps to owning and managing HASI, with 24-hour and historical pricing before you buy.
Steps to owning and managing GRIF, with 24-hour and historical pricing before you buy.
Steps to owning and managing FSBW, with 24-hour and historical pricing before you buy.
Steps to owning and managing FNWB, with 24-hour and historical pricing before you buy.
Steps to owning and managing FXNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing FMNB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.